ea0094oc4.3 | Reproductive Endocrinology | SFEBES2023
Grant Bonnie
, Campbell John
, Pradeep Anjali
, Burns Angela D.
, Bassett Paul
, Abbara Ali
, Saket Priyadarshi
, Minhas Sukhbinder
, Dhillo Waljit S.
, McVeigh James
, Bhasin Shalender
, Jayasena Channa N.
Background: Millions of men worldwide take anabolic-androgenic steroids (AAS) to boost muscle growth, but risk psychosis, cardiomyopathy, stroke and death. Users avoid stopping AAS because they are fearful of low testosterone symptoms including sexual dysfunction, depression and suicidality. To avoid these symptoms, men often illicitly self-medicate a 212-week course of drugs including selective oestrogen receptor modulators to boost testicular function ...